Loading clinical trials...
Loading clinical trials...
This randomized, double-blind, placebo-controlled, parallel-arm study will evaluate the safety and exploratory efficacy and pharmacokinetics of RO4917523 in pediatric patients with fragile X syndrome....
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hoffmann-La Roche
NCT07209462 · Fragile X Syndrome
NCT06560242 · Fragile X Syndrome
NCT00768820 · Velocardiofacial Syndrome, Williams Syndrome, and more
NCT06139172 · Telomeric 22Q13 Monosomy Syndrome, Tuberous Sclerosis, and more
NCT06677866 · Fragile X Syndrome (FXS), Autism Spectrum Disorder
Long Beach, California
Sacramento, California
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions